Sphingosine pathway modulating compounds for the treatment of coronavirus … |
2022-9-15 |
2022-11-01 |
|
Method for detecting and quantifying dna methylation in a selected locus or … |
2022-6-29 |
2023-1-05 |
|
Use of organic cationic compounds to accelerate nucleic acid hybridization, … |
2022-6-02 |
2022-12-29 |
|
Immunomodulatory pharmaceutical compositions including a synthetic peptide and … |
2021-10-12 |
2022-1-27 |
|
Pharmaceutical compositions and methods targeting wnt pathway proteins |
2021-10-05 |
2022-1-27 |
|
Fluorescence quencher polymer conjugates and uses thereof |
2021-6-30 |
2022-1-27 |
|
Comprehensive and comparative flow cytometry-based methods for identifying the … |
2021-5-04 |
2021-9-30 |
|
Affinity tag nucleic acid and protein compositions and processes for using same |
2021-3-29 |
2021-7-15 |
|
Affinity tag nucleic acid and protein compositions and processes for using same |
2021-1-04 |
2021-6-03 |
|
Antibodies specific for sulfation sites of wnt pathway proteins |
2020-12-22 |
2021-6-03 |
|
Fluorescent dyes and methods of use thereof |
2020-11-19 |
2021-3-18 |
|
Sphingosine pathway modulating compounds for the treatment of cancers |
2020-11-19 |
2021-6-10 |
|
Monoazo dyes with cyclic amine as fluorescence quenchers |
2020-11-02 |
2021-3-18 |
|
Sphingosine pathway modulating compounds for the treatment of cancers |
2020-9-22 |
2021-1-07 |
|
Compositions for Preparing Regulatory T-Cell Compositions for the Treatment of … |
2020-9-09 |
2021-3-11 |
|
Immunomodulatory compositions and methods of use thereof |
2020-8-31 |
2021-2-11 |
|
Dyes for analysis of protein aggregation |
2020-8-06 |
2021-1-14 |
|
Nucleic acid probes for in situ hybridization |
2020-7-06 |
2020-10-22 |
|
Digallic acid for reduction of inflammatory cytokine activity |
2020-4-21 |
2020-11-19 |
|
Sulfonated sclerostin, antibodies, epitopes and methods for identification and … |
2020-3-26 |
2020-10-15 |
|
Diagnosis and treatment of viral diseases |
2019-10-15 |
2020-4-09 |
|
Sphingosine kinase type 1 inhibitors and uses thereof |
2019-9-17 |
2020-3-05 |
|
Methods and intermediates for synthesizing sk1-i |
2019-5-13 |
2020-4-30 |
|
Nucleic acid probes for in situ hybridization |
2019-4-25 |
2020-2-06 |
|
Sphingosine pathway modulating compounds for the treatment of cancers |
2018-12-21 |
2022-3-09 |
|
Hydroxycholesterol immunoassay |
2018-12-19 |
2019-12-19 |
|
Assays for detecting modified compounds |
2018-12-19 |
2019-5-30 |
|
Multisignal reagents for labeling analytes |
2018-11-28 |
2019-5-16 |
|
Immunomodulatory compositions and methods of use thereof |
2018-7-19 |
2019-1-24 |
|
Compounds and methods for detection of enzymes that remove formyl, succinyl, … |
2018-4-03 |
2018-8-09 |
|
Multisignal labeling reagents and processes and uses therefor |
2017-12-21 |
2018-5-10 |
|
Methods for treating melanoma |
2017-10-11 |
2018-2-08 |
|
Immunomodulatory pharmaceutical compositions and methods of use thereof |
2017-9-29 |
2019-4-02 |
2019-4-02 |
Beta glycolipids as immuno-modulators |
2017-2-27 |
2017-4-30 |
|
Diagnosis and treatment of viral diseases |
2017-2-22 |
2018-4-03 |
2018-4-03 |
Self-Immolative Probes for Enzyme Activity Detection |
2017-1-26 |
2017-5-18 |
|
Profiling reactive oxygen, nitrogen and halogen species |
2017-1-10 |
2017-5-04 |
|
Methods for inhibiting cellular uptake of the anthrax lethal toxin (lt) protein … |
2016-11-29 |
2017-3-16 |
|
Pharmaceutical compositions targeting WNT pathway proteins |
2016-6-28 |
2019-6-25 |
2019-6-25 |
Processes for detecting or quantifying more than one nucleic acid in a library |
2016-3-21 |
2016-7-21 |
|
Processes for quantitative or qualitative detection of single-stranded or … |
2016-2-26 |
2018-12-04 |
2018-12-04 |
Comprehensive and comparative flow cytometry-based methods for identifying the … |
2015-8-26 |
2016-6-30 |
|
Diagnosis and treatment of viral diseases |
2013-11-14 |
2014-12-18 |
|
Diagnosis and treatment of viral diseases |
2013-6-18 |
2014-7-10 |
|
Sclerostin and the inhibition of wnt signaling and bone formation |
2013-5-01 |
2013-9-26 |
|
Vitamin d assays |
2013-3-14 |
2014-9-18 |
|
Fluorescent dyes |
2013-1-03 |
2013-5-09 |
|
Compositions and methods for bone formation and modeling |
2012-11-14 |
2015-3-03 |
2015-3-03 |
Multisignal reagents for labeling analytes |
2012-7-24 |
2014-1-30 |
|
Optimized real time nucleic acid detection processes |
2012-3-30 |
2012-10-04 |
|
Mutant t7 polymerases |
2011-9-13 |
2012-3-22 |
|
Multi-oligomeric or multi-polymeric compositions comprising labeled moieties … |
2010-6-24 |
2013-3-05 |
2013-3-05 |
Autophagy and phospholipidosis pathway assays |
2009-9-14 |
2010-4-15 |
|
Processes for treating subjects carrying viral infectious agent |
2009-8-18 |
2010-1-28 |
|
Compositions useful for detection or quantification of desirable target … |
2009-6-17 |
2012-2-16 |
|
Methods of effecting wnt signaling through dkk structural analysis |
2009-5-28 |
2011-4-06 |
|
Compounds and assays for controlling Wnt activity |
2009-5-22 |
2012-12-20 |
|
Novel sphingosine kinase type 1 inhibitors, compositions and processes for … |
2009-4-29 |
2010-2-11 |
|
Labeling of target molecules, identification of organelles and other … |
2008-12-04 |
2013-1-22 |
2013-1-22 |
Fluorochromes for organelle tracing and multi-color imaging |
2008-9-08 |
2010-3-11 |
|
Compositions and methods for the inhibition of dishevelled proteins |
2007-10-07 |
2008-1-20 |
|
Antibodies against april as biomarkers for early prognosis of lymphoma patients |
2006-9-22 |
2011-6-16 |
|
Purine based fluorescent dyes |
2005-7-07 |
2010-6-15 |
2010-6-15 |
Selective detection of oncogenic HPV |
2005-7-06 |
2009-7-30 |
|
Compositions and methods for the stimulation or enhancement of bone formation … |
2005-5-18 |
2014-3-26 |
2014-3-26 |
Educated NKT cells and their uses in the treatment of immune-related disorders. |
2004-9-20 |
2012-9-05 |
|
Compositions and Methods for Bone Formation and Remodeling |
2004-5-19 |
2006-9-07 |
|
Chemiluminescent reagents |
2004-1-23 |
2007-8-14 |
2007-8-14 |
Transmucosal administration of aggregated antigens |
2003-10-17 |
2014-6-24 |
2014-6-24 |